Meeting Report for Technical Consultation on In Vitro Diagnostics for AMR, 27–28 March 2019. Geneva: World Health Organization; 2019
(2019; 11 pages)

Abstract

The Technical Consultation on In Vitro Diagnostics on AMR was held on 27–28 March 2019 at WHO headquarters in Geneva, Switzerland. The agenda and list of participants for the meeting are attached as Annex A and Annex B, respectively.

The meeting had the following objectives:

  • review a draft landscape of in vitro diagnostics (IVDs) to combat antimicrobial resistance (AMR) (with a focus on antibacterial resistance [ABR]);
  • identify gaps in such diagnostics suitable for use in patient management at primary and secondary healthcare facilities (Levels I and II) in lowand middle-income countries (LMICs);
  • agree on a research and development (R&D) priority list of diagnostics for use in Levels I and II in those settings; and
  • identify priorities for target product profiles (TPPs) for the highest-priority AMR diagnostics to be developed.
Related documents
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 1, 2019